NCT00834418View on ClinicalTrials.gov

Leflunomide 20 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Healthy
Interventions
DRUG

Leflunomide 20 mg Tablets

1 x 20 mg, single-dose fasting

DRUG

ARAVA™ 20 mg Tablets

1 x 20 mg, single-dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834418 - Leflunomide 20 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter